<SEC-DOCUMENT>0000905718-19-000789-index.html : 20190926
<SEC-HEADER>0000905718-19-000789.hdr.sgml : 20190926
<ACCEPTANCE-DATETIME>20190926161623
ACCESSION NUMBER:		0000905718-19-000789
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190924
FILED AS OF DATE:		20190926
DATE AS OF CHANGE:		20190926

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			TYNDALL CAPITAL PARTNERS L P
		CENTRAL INDEX KEY:			0001219314
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36020
		FILM NUMBER:		191118064

	BUSINESS ADDRESS:	
		STREET 1:		150 EAST 58TH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10155
		BUSINESS PHONE:		212-446-2466

	MAIL ADDRESS:	
		STREET 1:		150 EAST 58TH STREET
		STREET 2:		14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10155

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Onconova Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001130598
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		375 PHEASANT RUN
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940
		BUSINESS PHONE:		267-759-3681

	MAIL ADDRESS:	
		STREET 1:		375 PHEASANT RUN
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCONOVA THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20090526

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCONOVA THERAPEUTICS INC
		DATE OF NAME CHANGE:	20001226
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>onconova_fm4sept242019.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: onconova_fm4sept242019.html

Document 1 - RAW XML: onconova_fm4sept242019.xml

</DOCUMENT>
</SEC-DOCUMENT>